Matches in SemOpenAlex for { <https://semopenalex.org/work/W2069041300> ?p ?o ?g. }
- W2069041300 endingPage "219" @default.
- W2069041300 startingPage "191" @default.
- W2069041300 abstract "Over the past two decades, platinum-based drugs (cisplatin and, latterly, the less toxic analogue carboplatin) have conferred significant therapeutic benefit to a large number of cancer sufferers. However, there remains scope for substantial improvement in the clinical utility of metal coordination complexes through the discovery of additional platinum-based complexes (or possibly alternative metals). Future drug discovery strategies should focus on tumor resistance and its circumvention. To date, only one series of compounds, those containing a 1,2-diaminocyclohexane carrier ligand (e.g., oxaliplatin, tetraplatin), has entered clinical trial based on their circumvention of acquired cisplatin resistance in some (mainly murine) preclinical tumor models. At present these agents are in early clinical trial and thus their true clinical utility in cisplatin/carboplatin refractory disease is not yet determinable (and may not be due to dose-limiting neurotoxicity). Over the past few years, our understanding of mechanisms of resistance to cisplatin and its interaction with DNA has vastly increased. This new information will undoubtedly guide the development of new strategies aimed at the circumvention of intrinsic and acquired tumor resistance to cisplatin. Approaches to circumvent resistance will probably involve not only the rational development of a new generation of platinum-based drugs (e.g., compounds designed to overcome reduced cisplatin accumulation or enhanced removal of cisplatin-induced DNA adducts) but also non-platinum drugs which are capable of modulating resistance (e.g., modulators of signal transduction pathways, ras and myc oncogene expression and glutathione biosynthesis). One may look forward with a great deal of optimism that these promising new approaches will result in clinical benefit by the end of the century. Nevertheless, cisplatin and carboplatin remain the standard anticancer drugs to which novel platinum-based complexes must be compared." @default.
- W2069041300 created "2016-06-24" @default.
- W2069041300 creator A5041062763 @default.
- W2069041300 date "1993-12-01" @default.
- W2069041300 modified "2023-10-14" @default.
- W2069041300 title "New platinum antitumor complexes" @default.
- W2069041300 cites W149386898 @default.
- W2069041300 cites W1512601207 @default.
- W2069041300 cites W1521601065 @default.
- W2069041300 cites W1528896526 @default.
- W2069041300 cites W1534946515 @default.
- W2069041300 cites W1581575889 @default.
- W2069041300 cites W1911440094 @default.
- W2069041300 cites W1963704398 @default.
- W2069041300 cites W1965059247 @default.
- W2069041300 cites W1967061702 @default.
- W2069041300 cites W1967635885 @default.
- W2069041300 cites W1969158270 @default.
- W2069041300 cites W1969270599 @default.
- W2069041300 cites W1970958639 @default.
- W2069041300 cites W1972562299 @default.
- W2069041300 cites W1972972637 @default.
- W2069041300 cites W1973073879 @default.
- W2069041300 cites W1974671082 @default.
- W2069041300 cites W1976453250 @default.
- W2069041300 cites W1976874431 @default.
- W2069041300 cites W1979086997 @default.
- W2069041300 cites W1979948020 @default.
- W2069041300 cites W1980543942 @default.
- W2069041300 cites W1980635047 @default.
- W2069041300 cites W1981534406 @default.
- W2069041300 cites W1982759189 @default.
- W2069041300 cites W1983075270 @default.
- W2069041300 cites W1983426353 @default.
- W2069041300 cites W1985499095 @default.
- W2069041300 cites W1987437563 @default.
- W2069041300 cites W1990733040 @default.
- W2069041300 cites W1992391103 @default.
- W2069041300 cites W1993732814 @default.
- W2069041300 cites W1994987544 @default.
- W2069041300 cites W1996131136 @default.
- W2069041300 cites W1997880224 @default.
- W2069041300 cites W2003003988 @default.
- W2069041300 cites W2003175719 @default.
- W2069041300 cites W2005483990 @default.
- W2069041300 cites W2005958803 @default.
- W2069041300 cites W2006850192 @default.
- W2069041300 cites W2007225433 @default.
- W2069041300 cites W2007958204 @default.
- W2069041300 cites W2008561915 @default.
- W2069041300 cites W2010847547 @default.
- W2069041300 cites W2012936999 @default.
- W2069041300 cites W2013478379 @default.
- W2069041300 cites W2014896394 @default.
- W2069041300 cites W2015283376 @default.
- W2069041300 cites W2019583985 @default.
- W2069041300 cites W2020005203 @default.
- W2069041300 cites W2022383292 @default.
- W2069041300 cites W2024434976 @default.
- W2069041300 cites W2024844244 @default.
- W2069041300 cites W2025293912 @default.
- W2069041300 cites W2025501714 @default.
- W2069041300 cites W2026327431 @default.
- W2069041300 cites W2026880745 @default.
- W2069041300 cites W2031757938 @default.
- W2069041300 cites W2032171886 @default.
- W2069041300 cites W2033064838 @default.
- W2069041300 cites W2033321871 @default.
- W2069041300 cites W2033658150 @default.
- W2069041300 cites W2034865549 @default.
- W2069041300 cites W2034873169 @default.
- W2069041300 cites W2036693363 @default.
- W2069041300 cites W2037841381 @default.
- W2069041300 cites W2038170131 @default.
- W2069041300 cites W2038601532 @default.
- W2069041300 cites W2039511877 @default.
- W2069041300 cites W2041064598 @default.
- W2069041300 cites W2041692277 @default.
- W2069041300 cites W2042044981 @default.
- W2069041300 cites W2042320307 @default.
- W2069041300 cites W2042795561 @default.
- W2069041300 cites W2044024856 @default.
- W2069041300 cites W2044640058 @default.
- W2069041300 cites W2045388444 @default.
- W2069041300 cites W2045701290 @default.
- W2069041300 cites W2046334666 @default.
- W2069041300 cites W2049726669 @default.
- W2069041300 cites W2051953724 @default.
- W2069041300 cites W2052457410 @default.
- W2069041300 cites W2056359433 @default.
- W2069041300 cites W2058078699 @default.
- W2069041300 cites W2059165422 @default.
- W2069041300 cites W2059234543 @default.
- W2069041300 cites W2062130291 @default.
- W2069041300 cites W2063134579 @default.
- W2069041300 cites W2065982243 @default.
- W2069041300 cites W2068521859 @default.
- W2069041300 cites W2069079191 @default.